Transmyocardial laser revascularization
A procedure by which a physician uses a laser to make holes in the heart to relieve the pain of severe angina.
Transmyocardial laser revascularization has been done from both the outside and inside of the heart. When done from the outside, a laser (carbon dioxide or holmium laser) is placed in proximity to the left ventricle of the heart and sufficient energy is applied to create small channels from the outside (epicardial) surface to the inside (endocardial) surface of the heart. Thus, a number (10-50) of tiny holes are created right through the heart muscle (the myocardium). More recently, this procedure has moved into the cardiac catheterization lab and the laser works from the inside outward.
Angina is due to oxygen deprivation of the heart muscle. The channels made by the laser are intended to improve the perfusion of the oxygen- deprived heart muscle by giving it direct access to the oxygen-rich blood from the left ventricle. This does not happen for long, because the channels quickly fill with blood clot. Further, the procedure does not noticeably improve the function of the heart. Nonetheless, transmyocardial laser revascularization appears to lessen or abolish the pain in patients with severe angina, at least for a while.
This procedure was originally done by heart surgery and carried an overall mortality rate of about 5 percent. The major hazards are arrhythmias (abnormal hear rhythms) and tamponade due to complete penetration of the heart. Tamponade is a life-threatening situation in which there is such a large amount of blood inside the pericardial sac around the heart that it interferes with the performance of the heart.
One-year data from three major randomized trials reported late in 1999 showed that transmyocardial revascularization (TMR), either by the open chest method or percutaneously, was superior in terms of angina relief and improvement in exercise tolerance to maximal medical therapy.
A procedure by which a physician uses a laser to make holes in the heart to relieve the pain of severe angina.
Transmyocardial laser revascularization has been done from both the outside and inside of the heart. When done from the outside, a laser (carbon dioxide or holmium laser) is placed in proximity to the left ventricle of the heart and sufficient energy is applied to create small channels from the outside (epicardial) surface to the inside (endocardial) surface of the heart. Thus, a number (10-50) of tiny holes are created right through the heart muscle (the myocardium). More recently, this procedure has moved into the cardiac catheterization lab and the laser works from the inside outward.
Angina is due to oxygen deprivation of the heart muscle. The channels made by the laser are intended to improve the perfusion of the oxygen- deprived heart muscle by giving it direct access to the oxygen-rich blood from the left ventricle. This does not happen for long, because the channels quickly fill with blood clot. Further, the procedure does not noticeably improve the function of the heart. Nonetheless, transmyocardial laser revascularization appears to lessen or abolish the pain in patients with severe angina, at least for a while.
This procedure was originally done by heart surgery and carried an overall mortality rate of about 5 percent. The major hazards are arrhythmias (abnormal hear rhythms) and tamponade due to complete penetration of the heart. Tamponade is a life-threatening situation in which there is such a large amount of blood inside the pericardial sac around the heart that it interferes with the performance of the heart.
One-year data from three major randomized trials reported late in 1999 showed that transmyocardial revascularization (TMR), either by the open chest method or percutaneously, was superior in terms of angina relief and improvement in exercise tolerance to maximal medical therapy.
Read Also:
- Transplant
The grafting of a tissue from one place to another, just as in botany a bud from one plant might be grafted onto the stem of another. The transplanting of tissue can be from one part of the patient to another (autologous transplantation), as in the case of a skin graft using the patient’s own […]
- Transplant, hand and forearm
Transplantation of the hand and the forearm from one person (a deceased donor) to another (the recipient). In the first hand transplant, performed in Ecuador in 1964, the donor hand was rejected after two weeks. The first successful hand and forearm transplant was done in 1998 in Lyon, France. In 1999, surgeons in Louisville, Kentucky, […]
- Transplant, lung
The first lung transplant was done by the American surgeon James Hardy (1918-) in 1964.
- Transplant, renal
Replacement of a diseased, damaged, or missing kidney with a donor kidney. Also called a kidney transplant. Patients with end-stage renal failure are candidates for transplantation. A successful transplant frees the patient from dialysis and provides the kidney’s other metabolic functions. The survival rate a year after a transplant from a living related donor is […]
- Transplantation genetics
class I (HLA-A,B,Cw), class II (HLA-DR,DQ,DP) and class III (no HLA genes). The need for HLA matching depends on the type of transplant. In bone marrow transplantation, HLA matching is an absolute necessity, lest the cells be rejected. In corneal transplantation, HLA matching is less relevant because of the lack of blood vessels in the […]